SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $35,838,000 | -47.3% | 1,306,520 | +18.0% | 0.01% | -54.5% |
Q3 2016 | $67,988,000 | +240.0% | 1,107,119 | +5.6% | 0.01% | +266.7% |
Q2 2016 | $19,997,000 | -4.2% | 1,048,618 | -1.9% | 0.00% | 0.0% |
Q1 2016 | $20,865,000 | -48.2% | 1,068,913 | +2.5% | 0.00% | -57.1% |
Q4 2015 | $40,243,000 | +33.9% | 1,043,114 | +11.4% | 0.01% | +40.0% |
Q3 2015 | $30,060,000 | -10.9% | 936,149 | -15.5% | 0.01% | 0.0% |
Q2 2015 | $33,726,000 | +117.3% | 1,108,316 | -5.2% | 0.01% | +150.0% |
Q1 2015 | $15,523,000 | -8.2% | 1,168,899 | +0.0% | 0.00% | -33.3% |
Q4 2014 | $16,910,000 | -25.6% | 1,168,604 | +8.5% | 0.00% | -25.0% |
Q3 2014 | $22,720,000 | -28.5% | 1,076,769 | +0.9% | 0.00% | -20.0% |
Q2 2014 | $31,792,000 | +27.8% | 1,067,216 | +3.1% | 0.01% | +25.0% |
Q1 2014 | $24,883,000 | +22.8% | 1,035,510 | +4.1% | 0.00% | 0.0% |
Q4 2013 | $20,265,000 | -52.5% | 994,843 | +10.1% | 0.00% | -50.0% |
Q3 2013 | $42,688,000 | +31.2% | 903,834 | +5.7% | 0.01% | +14.3% |
Q2 2013 | $32,528,000 | – | 855,128 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |